BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12096274)

  • 1. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall.
    Nagashima H; Aoka Y; Sakomura Y; Sakuta A; Aomi S; Ishizuka N; Hagiwara N; Kawana M; Kasanuki H
    J Vasc Surg; 2002 Jul; 36(1):158-63. PubMed ID: 12096274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
    Wilson WR; Evans J; Bell PR; Thompson MM
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):259-62. PubMed ID: 16009575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm.
    Rahman MN; Khan JA; Mazari FA; Mockford K; McCollum PT; Chetter IC
    Ann Vasc Surg; 2011 Jan; 25(1):32-8. PubMed ID: 20889295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall.
    Nagashima H; Aoka Y; Sakomura Y; Uto K; Sakuta A; Aomi S; Kurosawa H; Hagiwara N; Kawana M; Kasanuki H
    J Vasc Surg; 2004 Feb; 39(2):447-53. PubMed ID: 14743151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue.
    Yoshimura K; Nagasawa A; Kudo J; Onoda M; Morikage N; Furutani A; Aoki H; Hamano K
    Int J Mol Sci; 2015 May; 16(5):11213-28. PubMed ID: 25993292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
    Thompson RW; Baxter BT
    Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
    Abdul-Hussien H; Hanemaaijer R; Verheijen JH; van Bockel JH; Geelkerken RH; Lindeman JH
    J Vasc Surg; 2009 Mar; 49(3):741-9. PubMed ID: 19268776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix.
    Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW
    J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
    Luan Z; Chase AJ; Newby AC
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominal Aortic Aneurysm-Associated MicroRNA-516a-5p Regulates Expressions of Methylenetetrahydrofolate Reductase, Matrix Metalloproteinase-2, and Tissue Inhibitor of Matrix Metalloproteinase-1 in Human Abdominal Aortic Vascular Smooth Muscle Cells.
    Chan CYT; Cheuk BLY; Cheng SWK
    Ann Vasc Surg; 2017 Jul; 42():263-273. PubMed ID: 28288890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology.
    Hurks R; Hoefer IE; Vink A; Pasterkamp G; Schoneveld A; Kerver M; de Vries JP; Tangelder MJ; Moll FL
    Eur J Vasc Endovasc Surg; 2010 May; 39(5):569-76. PubMed ID: 20226696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro.
    Aikawa M; Rabkin E; Sugiyama S; Voglic SJ; Fukumoto Y; Furukawa Y; Shiomi M; Schoen FJ; Libby P
    Circulation; 2001 Jan; 103(2):276-83. PubMed ID: 11208689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction.
    Chew DK; Conte MS; Khalil RA
    J Vasc Surg; 2004 Nov; 40(5):1001-10. PubMed ID: 15557917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm.
    Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J
    PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
    Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
    J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and localization of membrane type-1 matrix metalloproteinase in human abdominal aortic aneurysms.
    Nollendorfs A; Greiner TC; Nagase H; Baxter BT
    J Vasc Surg; 2001 Aug; 34(2):316-22. PubMed ID: 11496285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms.
    Verschuren L; Lindeman JH; van Bockel JH; Abdul-Hussien H; Kooistra T; Kleemann R
    Antioxid Redox Signal; 2005; 7(9-10):1195-202. PubMed ID: 16115023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall.
    Kajimoto K; Miyauchi K; Kasai T; Shimada K; Kojima Y; Shimada A; Niinami H; Amano A; Daida H
    Atherosclerosis; 2009 Oct; 206(2):505-11. PubMed ID: 19406402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of the mechanisms by which 3,4-benzopyrene promotes angiotensin II-induced abdominal aortic aneurysm formation in mice.
    Ji K; Zhang Y; Jiang F; Qian L; Guo H; Hu J; Liao L; Tang J
    J Vasc Surg; 2014 Feb; 59(2):492-9. PubMed ID: 23676189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.